Autophagy in age-related macular degeneration

K Kaarniranta, J Blasiak, P Liton, M Boulton… - Autophagy, 2023 - Taylor & Francis
Age-related macular degeneration (AMD) is the leading cause of visual impairment in the
aging population with limited understanding of its pathogenesis and a lack of effective …

The role of vitamin A in retinal diseases

J Sajovic, A Meglič, D Glavač, Š Markelj… - International journal of …, 2022 - mdpi.com
Vitamin A is an essential fat-soluble vitamin that occurs in various chemical forms. It is
essential for several physiological processes. Either hyper-or hypovitaminosis can be …

The complement system, aging, and aging-related diseases

R Zheng, Y Zhang, K Zhang, Y Yuan, S Jia… - International Journal of …, 2022 - mdpi.com
The complement system is a part of the immune system and consists of multiple complement
components with biological functions such as defense against pathogens and …

Transcriptomic and proteomic retinal pigment epithelium signatures of age-related macular degeneration

A Senabouth, M Daniszewski, GE Lidgerwood… - Nature …, 2022 - nature.com
There are currently no treatments for geographic atrophy, the advanced form of age-related
macular degeneration. Hence, innovative studies are needed to model this condition and …

The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy

GA Borchert, H Shamsnajafabadi, ML Hu, SR De Silva… - Cells, 2023 - mdpi.com
Age-related macular degeneration (AMD) is the leading cause of vision loss and visual
impairment in people over 50 years of age. In the current therapeutic landscape, intravitreal …

[HTML][HTML] Therapeutic targeting of the complement system in ocular disease

S Rathi, R Hasan, M Ueffing, SJ Clark - Drug discovery today, 2023 - Elsevier
The complement system is involved in the pathogenesis of several ocular diseases,
providing a rationale for the investigation of complement-targeting therapeutics for these …

Investigational drugs in clinical trials for macular degeneration

MJ Tolentino, AJ Tolentino - Expert Opinion on Investigational …, 2022 - Taylor & Francis
Introduction Intravitreal anti-vascular endothelial growth factor (VEGF) injections for
exudative age-related macular degeneration (eAMD) are effective and safe but require …

Therapy approaches for Stargardt disease

E Piotter, ME McClements, RE MacLaren - Biomolecules, 2021 - mdpi.com
Despite being the most prevalent cause of inherited blindness in children, Stargardt disease
is yet to achieve the same clinical trial success as has been achieved for other inherited …

Complement Inhibitors in Age‐Related Macular Degeneration: A Potential Therapeutic Option

S Qin, N Dong, M Yang, J Wang… - Journal of …, 2021 - Wiley Online Library
Age‐related macular degeneration (AMD) is a multifactorial disease, which can culminate in
irreversible vision loss and blindness in elderly. Nowadays, there is a big gap between dry …

The role of oxidative stress in the aging eye

D Goodman, S Ness - Life, 2023 - mdpi.com
Given the expanding elderly population in the United States and the world, it is important to
understand the processes underlying both natural and pathological age-related changes in …